Join Us for Biotalys' Upcoming Shareholders Meeting
Biotalys, an innovative Agricultural Technology (AgTech) company that focuses on developing protein-based biocontrols for sustainable crop protection, warmly invites its shareholders and other stakeholders to attend an important ordinary general shareholders meeting. This gathering is set to take place at the company’s headquarters, providing a great opportunity for engagement and discussion among investors.
Meeting Details and Voting Options
The shareholders meeting is scheduled for April 22, 2025, at 10:00 AM CEST. This annual event is vital for shareholders wishing to engage directly with the company’s strategies and future directions. In addition to attending in person, we understand the importance of convenience and flexibility for our shareholders. Therefore, voting rights can alternatively be exercised by mail or through a written proxy, ensuring that everyone has the chance to contribute, even if they cannot be present.
Engaging with the Agenda
As part of the company’s commitment to transparency, Biotalys encourages its securities holders to submit questions in advance concerning the items on the meeting agenda. This proactive approach not only enriches the discussions but also ensures that shareholders can make informed decisions regarding their investments. More detailed information on the process of voting by mail or proxy, as well as instructions for submitting questions, can be found in the convening notice that was distributed to all stakeholders.
Important Attendance Requirements
To attend the shareholders meeting, holders of Biotalys securities are required to adhere to specific regulations set forth in the Belgian Code of Companies and Associations as well as comply with the company’s Articles of Association. It is crucial for attendees to familiarize themselves with these requirements outlined in the convening notice to ensure a smooth and efficient meeting process.
Accessing Meeting Documents
All relevant documents for the shareholders meeting, including the convening notice, can be accessed on the Company’s official website. It is crucial for shareholders to stay informed and review these documents prior to the meeting to fully engage in all discussions.
About Biotalys
Founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology), Biotalys has been at the forefront of the AgTech industry, providing alternatives to conventional chemical pesticides. Our primary goal is to ensure a sustainable and safer food supply through innovative biocontrol solutions. With our cutting-edge AGROBODY™ technology platform, we are developing a diverse range of product candidates that boast a favorable safety profile, targeting significant crop pests and diseases throughout the agricultural value chain, from soil to plate.
As an integral part of the biotech cluster in Ghent, Belgium, Biotalys has established a solid presence in the market, being listed on Euronext Brussels since July 2021. We strive to continuously innovate and expand our offerings to meet the evolving needs of farmers and consumers alike.
Contact Us for More Information
For further inquiries, shareholders and interested parties are encouraged to reach out to Toon Musschoot, Head of Investor Relations and Communications at Biotalys. You can contact him directly at +32(0)9 274 54 00 or via email at IR@biotalys.com, where he will be happy to assist you.
Frequently Asked Questions
What is the date of the upcoming shareholders meeting?
The ordinary general shareholders meeting is scheduled for April 22, 2025, at 10:00 AM CEST.
How can I participate if I cannot attend the meeting in person?
Shareholders can participate by exercising their voting rights via mail or through a written proxy.
Is there an option to submit questions regarding the meeting agenda?
Yes, shareholders are encouraged to submit their questions in writing in advance of the meeting.
Where can I find the convening notice and other meeting documents?
All relevant documents, including the convening notice, are available on the Company’s official website.
Who can I contact for further information?
For any inquiries, please reach out to Toon Musschoot, Head of Investor Relations and Communications at +32(0)9 274 54 00 or via email at IR@biotalys.com.
